Table 6. Clinical and evolutional... | American Society of Hematology

Table 6.

Clinical and evolutional features of 114 patients with diffuse large B-cell lymphoma according to differentiation profile

	GC-CD10⁺(n = 24)	GC-CD10⁻ (n = 30)	pGC (n = 60)
Age, y, median (range)	63 (22-93)	68 (33-88)	64 (24-85)
Sex, no.
Male	10	15	27
Female	14	15	33
Primary extranodal origin, %	50	59^6-151	29
Advanced Ann Arbor stage (III/IV), %	73	30^6-152	53
High serum LDH, %^6-150	54	32^6-151	65
High/intermediate- or high-risk IPI, %^6-150	60	21^6-152	53
CR rate, %	50	69	55
5-y OS, %	43	57	40

	GC-CD10⁺(n = 24)	GC-CD10⁻ (n = 30)	pGC (n = 60)
Age, y, median (range)	63 (22-93)	68 (33-88)	64 (24-85)
Sex, no.
Male	10	15	27
Female	14	15	33
Primary extranodal origin, %	50	59^6-151	29
Advanced Ann Arbor stage (III/IV), %	73	30^6-152	53
High serum LDH, %^6-150	54	32^6-151	65
High/intermediate- or high-risk IPI, %^6-150	60	21^6-152	53
CR rate, %	50	69	55
5-y OS, %	43	57	40

n = 104 patients with available data.

P < .02 vs pGC group.

P < .04 vs the other 2 groups.